vs
QuidelOrtho Corp（QDEL）与越洋钻探（RIG）财务数据对比。点击上方公司名可切换其他公司
越洋钻探的季度营收约是QuidelOrtho Corp的1.5倍（$1.0B vs $699.9M），越洋钻探净利率更高（2.4% vs -104.7%，领先107.1%），越洋钻探同比增速更快（9.6% vs -3.7%），越洋钻探自由现金流更多（$321.0M vs $-94.7M），过去两年越洋钻探的营收复合增速更高（16.9% vs -2.9%）
奎德尔奥索公司是美国的诊断医疗产品制造商，旗下产品面向全球市场销售，深耕体外诊断领域，为医疗机构及相关用户提供专业的检测解决方案，助力全球医疗健康服务效率提升。
越洋钻探（Transocean Ltd.）是按营收计全球规模最大的海上钻探承包商，总部位于瑞士施泰因豪森，起源于美国，目前在加拿大、美国、挪威、英国、印度、巴西、新加坡等20个国家设有办事机构，业务覆盖全球主要海上油气开采区域。
QDEL vs RIG — 直观对比
营收规模更大
RIG
是对方的1.5倍
$699.9M
营收增速更快
RIG
高出13.3%
-3.7%
净利率更高
RIG
高出107.1%
-104.7%
自由现金流更多
RIG
多$415.7M
$-94.7M
两年增速更快
RIG
近两年复合增速
-2.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $699.9M | $1.0B |
| 净利润 | $-733.0M | $25.0M |
| 毛利率 | — | 42.0% |
| 营业利润率 | -100.7% | 23.0% |
| 净利率 | -104.7% | 2.4% |
| 营收同比 | -3.7% | 9.6% |
| 净利润同比 | -3583.4% | 257.1% |
| 每股收益（稀释后） | $-10.78 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QDELRIG
| Q4 25 | — | $1.0B | ||
| Q3 25 | $699.9M | $1.0B | ||
| Q2 25 | $613.9M | $988.0M | ||
| Q1 25 | $692.8M | $906.0M | ||
| Q4 24 | $707.8M | $952.0M | ||
| Q3 24 | $727.1M | $948.0M | ||
| Q2 24 | $637.0M | $861.0M | ||
| Q1 24 | $711.0M | $763.0M |
净利润QDELRIG
| Q4 25 | — | $25.0M | ||
| Q3 25 | $-733.0M | $-1.9B | ||
| Q2 25 | $-255.4M | $-938.0M | ||
| Q1 25 | $-12.7M | $-79.0M | ||
| Q4 24 | $-178.4M | $7.0M | ||
| Q3 24 | $-19.9M | $-494.0M | ||
| Q2 24 | $-147.7M | $-123.0M | ||
| Q1 24 | $-1.7B | $98.0M |
毛利率QDELRIG
| Q4 25 | — | 42.0% | ||
| Q3 25 | — | 43.2% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 31.8% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 40.6% | ||
| Q2 24 | — | 38.0% | ||
| Q1 24 | — | 31.5% |
营业利润率QDELRIG
| Q4 25 | — | 23.0% | ||
| Q3 25 | -100.7% | -163.1% | ||
| Q2 25 | -29.4% | -97.6% | ||
| Q1 25 | 4.7% | 7.1% | ||
| Q4 24 | -14.2% | 13.7% | ||
| Q3 24 | 2.1% | -51.2% | ||
| Q2 24 | -18.4% | -6.9% | ||
| Q1 24 | -247.3% | -0.4% |
净利率QDELRIG
| Q4 25 | — | 2.4% | ||
| Q3 25 | -104.7% | -187.1% | ||
| Q2 25 | -41.6% | -94.9% | ||
| Q1 25 | -1.8% | -8.7% | ||
| Q4 24 | -25.2% | 0.7% | ||
| Q3 24 | -2.7% | -52.1% | ||
| Q2 24 | -23.2% | -14.3% | ||
| Q1 24 | -239.9% | 12.8% |
每股收益（稀释后）QDELRIG
| Q4 25 | — | $0.13 | ||
| Q3 25 | $-10.78 | $-2.00 | ||
| Q2 25 | $-3.77 | $-1.06 | ||
| Q1 25 | $-0.19 | $-0.11 | ||
| Q4 24 | $-2.54 | $-0.14 | ||
| Q3 24 | $-0.30 | $-0.58 | ||
| Q2 24 | $-2.20 | $-0.15 | ||
| Q1 24 | $-25.50 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.1M | $620.0M |
| 总债务越低越好 | $2.5B | $5.2B |
| 股东权益账面价值 | $2.0B | $8.1B |
| 总资产 | $5.7B | $15.6B |
| 负债/权益比越低杠杆越低 | 1.23× | 0.64× |
8季度趋势，按日历期对齐
现金及短期投资QDELRIG
| Q4 25 | — | $620.0M | ||
| Q3 25 | $98.1M | $833.0M | ||
| Q2 25 | $151.7M | $377.0M | ||
| Q1 25 | $127.1M | $263.0M | ||
| Q4 24 | $98.3M | $560.0M | ||
| Q3 24 | $143.7M | $435.0M | ||
| Q2 24 | $107.0M | $475.0M | ||
| Q1 24 | $78.5M | $446.0M |
总债务QDELRIG
| Q4 25 | — | $5.2B | ||
| Q3 25 | $2.5B | $4.8B | ||
| Q2 25 | $2.1B | $5.9B | ||
| Q1 25 | $2.1B | $5.9B | ||
| Q4 24 | $2.1B | $6.2B | ||
| Q3 24 | $2.2B | $6.5B | ||
| Q2 24 | $2.2B | $6.8B | ||
| Q1 24 | $2.2B | $6.8B |
股东权益QDELRIG
| Q4 25 | — | $8.1B | ||
| Q3 25 | $2.0B | $8.1B | ||
| Q2 25 | $2.8B | $9.4B | ||
| Q1 25 | $3.0B | $10.2B | ||
| Q4 24 | $3.0B | $10.3B | ||
| Q3 24 | $3.2B | $10.2B | ||
| Q2 24 | $3.2B | $10.7B | ||
| Q1 24 | $3.3B | $10.5B |
总资产QDELRIG
| Q4 25 | — | $15.6B | ||
| Q3 25 | $5.7B | $16.2B | ||
| Q2 25 | $6.4B | $17.8B | ||
| Q1 25 | $6.5B | $19.0B | ||
| Q4 24 | $6.4B | $19.4B | ||
| Q3 24 | $6.8B | $19.5B | ||
| Q2 24 | $6.7B | $20.3B | ||
| Q1 24 | $6.7B | $19.9B |
负债/权益比QDELRIG
| Q4 25 | — | 0.64× | ||
| Q3 25 | 1.23× | 0.60× | ||
| Q2 25 | 0.74× | 0.63× | ||
| Q1 25 | 0.70× | 0.58× | ||
| Q4 24 | 0.72× | 0.60× | ||
| Q3 24 | 0.68× | 0.64× | ||
| Q2 24 | 0.70× | 0.63× | ||
| Q1 24 | 0.68× | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-45.5M | $349.0M |
| 自由现金流经营现金流 - 资本支出 | $-94.7M | $321.0M |
| 自由现金流率自由现金流/营收 | -13.5% | 30.8% |
| 资本支出强度资本支出/营收 | 7.0% | 2.7% |
| 现金转化率经营现金流/净利润 | — | 13.96× |
| 过去12个月自由现金流最近4个季度 | $-153.1M | $626.0M |
8季度趋势，按日历期对齐
经营现金流QDELRIG
| Q4 25 | — | $349.0M | ||
| Q3 25 | $-45.5M | $246.0M | ||
| Q2 25 | $-46.8M | $128.0M | ||
| Q1 25 | $65.6M | $26.0M | ||
| Q4 24 | $63.7M | $206.0M | ||
| Q3 24 | $117.9M | $194.0M | ||
| Q2 24 | $-97.9M | $133.0M | ||
| Q1 24 | $-700.0K | $-86.0M |
自由现金流QDELRIG
| Q4 25 | — | $321.0M | ||
| Q3 25 | $-94.7M | $235.0M | ||
| Q2 25 | $-84.3M | $104.0M | ||
| Q1 25 | $9.4M | $-34.0M | ||
| Q4 24 | $16.5M | $177.0M | ||
| Q3 24 | $71.4M | $136.0M | ||
| Q2 24 | $-133.2M | $49.0M | ||
| Q1 24 | $-66.8M | $-169.0M |
自由现金流率QDELRIG
| Q4 25 | — | 30.8% | ||
| Q3 25 | -13.5% | 22.9% | ||
| Q2 25 | -13.7% | 10.5% | ||
| Q1 25 | 1.4% | -3.8% | ||
| Q4 24 | 2.3% | 18.6% | ||
| Q3 24 | 9.8% | 14.3% | ||
| Q2 24 | -20.9% | 5.7% | ||
| Q1 24 | -9.4% | -22.1% |
资本支出强度QDELRIG
| Q4 25 | — | 2.7% | ||
| Q3 25 | 7.0% | 1.1% | ||
| Q2 25 | 6.1% | 2.4% | ||
| Q1 25 | 8.1% | 6.6% | ||
| Q4 24 | 6.7% | 3.0% | ||
| Q3 24 | 6.4% | 6.1% | ||
| Q2 24 | 5.5% | 9.8% | ||
| Q1 24 | 9.3% | 10.9% |
现金转化率QDELRIG
| Q4 25 | — | 13.96× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 29.43× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
RIG
| Ultra Deepwater Floaters | $433.0M | 42% |
| BR | $236.0M | 23% |
| Other Geographical | $211.0M | 20% |
| Harsh Environment Floaters | $163.0M | 16% |
